(Q40368785)

19 September 2017

1 reference

title

Growth hormone and calcitriol as modifiers of bone formation in renal osteodystrophy (English)

1 reference

19 September 2017

I B Salusky

1

1 reference

19 September 2017

W G Goodman

series ordinal

2

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 September 1995

1 reference

19 September 2017

1 reference

19 September 2017

volume

48

1 reference

19 September 2017

issue

3

1 reference

19 September 2017

page(s)

657-665

1 reference

A Review: Short Stature in Renal Disease

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Growth pattern and dietary intake of children with chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Renal osteodystrophy in children: the role of vitamin D, phosphorus, and parathyroid hormone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Stimulating growth in uremic children

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Accelerated growth after recombinant human growth hormone treatment of children with chronic renal failure.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Growth-stimulating effects of recombinant human growth hormone in children with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Growth hormone and adult bone remodelling

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Growth Hormone and Bone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Growth hormone and bone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicenter randomized double-blind placebo-controlled study. Genentech Cooperative Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Unique Biosynthesis by Kidney of a Biologically Active Vitamin D Metabolite

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Reduced plasma concentration of 1,25-dihydroxyvitamin D in children with moderate renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Circulating vitamin D metabolite concentrations in childhood renal diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Calcium Metabolism in Early Chronic Renal Failure: Implications for the Pathogenesis of Hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Increased Growth after Long-Term Oral 1α,25-Vitamin D3in Childhood Renal Osteodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

A prospective, double-blind study of growth failure in children with chronic renal insufficiency and the effectiveness of treatment with calcitriol versus dihydrotachysterol. The Growth Failure in Children with Renal Diseases Investigators

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

The spectrum of bone disease in end-stage renal failure--an evolving disorder

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Adynamic bone disease with negative aluminium staining in predialysis patients: prevalence and evolution after maintenance dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

1,25 Dihydroxy-vitamin D3 in normal man and patients with renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Skeletal resistance to parathyroid hormone in renal failure. Studies in 105 human subjects.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

25-hydroxyvitamin D3 (calcifediol) therapy of juvenile renal osteodystrophy: beneficial effect on linear growth velocity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Comparison of the anabolic effects of synthetic parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34 on bone in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Hormonal stimulation of bone cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Carboxyl-terminal parathyroid hormone fragments stimulate osteoclast-like cell formation and osteoclastic activity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Parathyroid hormone induces sequential c-fos expression in bone cells in vivo: in situ localization of its receptor and c-fos messenger ribonucleic acids

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

The renal PTH/PTHrP receptor is down-regulated in rats with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

The effects of vitamin D metabolites on the plasma and matrix vesicle membranes of growth and resting cartilage cells in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

1,25-Dihydroxyvitamin D3 Differentially Regulates the Production of Insulin-Like Growth Factor I (IGF-I) and IGF-Binding Protein-4 in Mouse Osteoblasts*

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

In vitro effects of growth hormone and other hormones on chondrocytes and osteoblast-like cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Plasma growth hormone-binding activity is low in uraemic children.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Growth hormone levels in severe renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Expression of insulin-like growth factor-1 in uremic rats: growth hormone resistance and nutritional intake

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Reduced hepatic growth hormone (GH) receptor gene expression and increased plasma GH binding protein in experimental uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Accelerated growth in short children with chronic renal failure treated with both strict dietary therapy and recombinant growth hormone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Calcium Metabolism in Acromegaly

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Parathyroid Function in Acromegaly

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Calcium and vitamin D metabolism in acromegaly

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Bone mineral status in growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adults

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Effects of short term administration of recombinant human growth hormone to elderly people

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Hypercalciuria Due to Combined Growth Hormone and Calcitriol Therapy in Uremia: Effects of Growth Hormone on Mineral Homeostasis in 75% Nephrectomized Weanling Rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Recombinant human growth hormone treatment of children following renal transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

How safe is the treatment of uraemic children with recombinant human growth hormone?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Activation of renal 1,25-dihydroxyvitamin D3 synthesis by phosphate deprivation: evidence for a role for growth hormone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Skeletal response to recombinant human growth hormone (rhGH) in children treated with long-term corticosteroids

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Growth hormone stimulates longitudinal bone growth directly

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Growth hormone stimulates the proliferation of cultured chondrocytes from rabbit ear and rat rib growth cartilage

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Human growth hormone enhances chondrogenesis and osteogenesis in a tissue culture system of chondroprogenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Evidence for a direct effect of growth hormone on osteoblasts

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Renal bone disease 1990: an unmet challenge for the nephrologist

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Quantitative Histological Studies on the Pathogenesis of Uremic Bone Disease*

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Aplastic osteodystrophy without aluminum: the role of "suppressed" parathyroid function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Risk factors for renal osteodystrophy: a multivariant analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Comparison of intact, midregion, and carboxy terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Influence of long-term oral 1,25-dihydroxyvitamin D in childhood renal osteodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

"High-dose" calcitriol for control of renal osteodystrophy in children on CAPD.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Evolution of secondary hyperparathyroidism during oral calcitriol therapy in pediatric renal osteodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Growth of children following the initiation of dialysis: a comparison of three dialysis modalities

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

The effects of 1,25-dihydroxyvitamin D3 and dexamethasone on rat osteoblast-like primary cell cultures: receptor occupancy and functional expression patterns for three different bioresponses

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.335

7 January 2021

Identifiers

DOI

10.1038/KI.1995.335

1 reference

Dimensions Publication ID

19 September 2017

1037574576

0 references

1 reference